BridgeBio Pharma Inc BBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
28.48quote price arrow up+0.65 (+2.34%)
Volume
176,590
Close
27.83quote price arrow up+0.09 (+0.32%)
Volume
1,499,078
52 week range
12.75 - 44.32
Loading...
  • Open28.45
  • Day High28.78
  • Day Low27.17
  • Prev Close27.74
  • 52 Week High44.32
  • 52 Week High Date12/28/23
  • 52 Week Low12.75
  • 52 Week Low Date05/25/23

Key Stats

  • Market Cap5.208B
  • Shares Out187.13M
  • 10 Day Average Volume1.62M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-31.06

KEY STATS

  • Open28.45
  • Day High28.78
  • Day Low27.17
  • Prev Close27.74
  • 52 Week High44.32
  • 52 Week High Date12/28/23
  • 52 Week Low12.75
  • 52 Week Low Date05/25/23
  • Market Cap5.208B
  • Shares Out187.13M
  • 10 Day Average Volume1.62M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-31.06

RATIOS/PROFITABILITY

  • EPS (TTM)-3.23
  • P/E (TTM)-8.62
  • Fwd P/E (NTM)-8.82
  • EBITDA (TTM)-466.45M
  • ROE (TTM)-192.44%
  • Revenue (TTM)218.597M
  • Gross Margin (TTM)2.60%
  • Net Margin (TTM)-250.09%
  • Debt To Equity (MRQ)-163.50%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BridgeBio Pharma Inc

 

Profile

MORE
BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering, creating, testing and delivering transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. The Company's pipeline of development programs ranges from early science to advanced clinical trials that include Acoramidis (AG10), a next-generation small molecule near-complete transthyretin (TTR) stabilizer, for the...
Neil Kumar Ph.D.
President, Chief Executive Officer, Director
Brian Stephenson Ph.D.
Chief Financial Officer, Secretary
Address
3160 Porter Dr., Suite 250
Palo Alto, CA
94304
United States

Top Peers

SYMBOLLASTCHG%CHG
CRSP
CRISPR Therapeutics AG
55.89+0.82+1.49%
KRYS
Krystal Biotech Inc
161.10+0.87+0.54%
ALPN
Alpine Immune Sciences Inc
64.60UNCHUNCH
MDGL
Madrigal Pharmaceuticals Inc
229.84+13.79+6.38%
NUVL
Nuvalent Inc
70.35-2.14-2.95%